This HTML5 document contains 29 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n15https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
dbpedia-frhttp://fr.dbpedia.org/resource/
wikipedia-enhttp://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Cytoreductive_surgery
rdfs:label
Cytoreductive surgery Chirurgie cytoréductrice
rdfs:comment
Cytoreductive surgery (CRS) is a surgical procedure that aims to reduce the amount of cancer cells in the abdominal cavity for patients with tumors that have spread intraabdominally (peritoneal carcinomatosis). It is often used to treat ovarian cancer but can also be used for other abdominal malignancies. CRS is often used in combination with hyperthermic intraperitoneal chemotherapy (HIPEC), for some cancer diagnosis it considerably increases life expectancy and reduces the rate of cancer recurrence. La chirurgie cytoréductive est une intervention chirurgicale qui vise à réduire la quantité de cellules cancéreuses dans la cavité abdominale chez les patients atteints de tumeurs qui se sont propagées de manière intra-abdominale (carcinomatose péritonéale). Il est souvent utilisé pour traiter le cancer de l'ovaire, mais peut également être utilisé pour d'autres tumeurs malignes abdominales.
dcterms:subject
dbc:Cancer dbc:Surgery dbc:Mesothelioma
dbo:wikiPageID
43009299
dbo:wikiPageRevisionID
1086837005
dbo:wikiPageWikiLink
dbc:Surgery dbr:Peritoneal_carcinomatosis dbr:Paul_Sugarbaker dbr:Surface_epithelial-stromal_tumor dbr:Cancer dbr:Survival_rate dbc:Mesothelioma dbr:Tumor dbc:Cancer dbr:Hyperthermic_intraperitoneal_chemotherapy dbr:Side_effect
owl:sameAs
wikidata:Q96375802 dbpedia-fr:Chirurgie_cytoréductrice n15:C7ofK
dbp:wikiPageUsesTemplate
dbt:Reflist
dbo:abstract
Cytoreductive surgery (CRS) is a surgical procedure that aims to reduce the amount of cancer cells in the abdominal cavity for patients with tumors that have spread intraabdominally (peritoneal carcinomatosis). It is often used to treat ovarian cancer but can also be used for other abdominal malignancies. CRS is often used in combination with hyperthermic intraperitoneal chemotherapy (HIPEC), for some cancer diagnosis it considerably increases life expectancy and reduces the rate of cancer recurrence. Its main developer was Paul Sugarbaker who is known for the development of cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy, or HIPEC, a treatment alternately referred to as the Sugarbaker Procedure. La chirurgie cytoréductive est une intervention chirurgicale qui vise à réduire la quantité de cellules cancéreuses dans la cavité abdominale chez les patients atteints de tumeurs qui se sont propagées de manière intra-abdominale (carcinomatose péritonéale). Il est souvent utilisé pour traiter le cancer de l'ovaire, mais peut également être utilisé pour d'autres tumeurs malignes abdominales. La chirurgie cytoréductive est souvent utilisé en association avec la chimiothérapie intrapéritonéale hyperthermique (CHIP), pour certains diagnostics de cancer, il augmente considérablement l'espérance de vie et réduit le taux de récidive du cancer .
prov:wasDerivedFrom
wikipedia-en:Cytoreductive_surgery?oldid=1086837005&ns=0
dbo:wikiPageLength
3775
foaf:isPrimaryTopicOf
wikipedia-en:Cytoreductive_surgery